The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
New approaches and challenges to targeting the endocannabinoid system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Self-citationCannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Self-citationHuang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
Self-citationDe Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Self-citationThiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00379-8 · Cited by 900
Phytocannabinoids: a unified critical inventory
Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., & Appendino, G. (2016) · Natural Product Reports · doi:10.1039/c6np00074f · Cited by 844
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., Gomis, R., Claret, M., & Cani, P. D. (2015) · Scientific Reports · doi:10.1038/srep16643 · Cited by 798
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Self-citationLactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Nomura, D. K., Morrison, B. E., Blankman, J. L., Long, J. Z., Kinsey, S. G., Marcondes, M. C. G., Ward, A. M., Hahn, Y. K., Lichtman, A. H., Conti, B., et al. (2011) · Science · doi:10.1126/science.1209200 · Cited by 727
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.06.008 · Cited by 622
McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030325 · Cited by 617
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Silvestri, C., & Di Marzo, V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.001 · Cited by 543
Self-citationEvidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Self-citationCannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 532
McPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 521
Self-citationCommensal bacteria make GPCR ligands that mimic human signalling molecules
Cohen, L. J., Esterhazy, D., Kim, S.-H., Lemetre, C., Aguilar, R. R., Gordon, E. A., Pickard, A. J., Cross, J. R., Emiliano, A. B., Han, S. M., et al. (2017) · Nature · doi:10.1038/nature23874 · Cited by 500
Mechoulam, R., & Shvo, Y. (1963) · Tetrahedron · doi:10.1016/0040-4020(63)85022-x · Cited by 486
Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03328.x · Cited by 475
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Self-citationCannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 462
Identification of GPR55 as a lysophosphatidylinositol receptor
Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.078 · Cited by 459
Högestätt, E. D., Jönsson, B. A. G., Ermund, A., Andersson, D. A., Björk, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., & Zygmunt, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501489200 · Cited by 454
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_2 · Cited by 446
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 439
The Endocannabinoid System and its Modulation by Phytocannabinoids
Di Marzo, V., & Piscitelli, F. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0374-6 · Cited by 432
Self-citationIannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A., Soubrane, C., Mazzarella, E., Russo, E., Whalley, B. J., Di Marzo, V., & Stephens, G. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000524 · Cited by 413
Self-citationQin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 393
Self-citationLong, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim-Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 391
BISOGNO, T., MELCK, D., BOBROV, M. Y., GRETSKAYA, N. M., BEZUGLOV, V. V., De PETROCELLIS, L., & Di MARZO, V. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510817 · Cited by 381
Self-citationHuggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375
Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Guida, F., Turco, F., Iannotta, M., De Gregorio, D., Palumbo, I., Sarnelli, G., Furiano, A., Napolitano, F., Boccella, S., Luongo, L., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.09.001 · Cited by 367
Marsch, R., Foeller, E., Rammes, G., Bunck, M., Kössl, M., Holsboer, F., Zieglgänsberger, W., Landgraf, R., Lutz, B., & Wotjak, C. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3303-06.2007 · Cited by 359
N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia
Chu, C. J., Huang, S. M., De Petrocellis, L., Bisogno, T., Ewing, S. A., Miller, J. D., Zipkin, R. E., Daddario, N., Appendino, G., Di Marzo, V., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211231200 · Cited by 345
Self-citationHuang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., De Petrocellis, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107351200 · Cited by 339
Self-citationDe Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
Self-citationActivity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
van Esbroeck, A. C. M., Janssen, A. P. A., Cognetta, A. B., Ogasawara, D., Shpak, G., van der Kroeg, M., Kantae, V., Baggelaar, M. P., de Vrij, F. M. S., Deng, H., et al. (2017) · Science · doi:10.1126/science.aaf7497 · Cited by 332
Tsuboi, K., Sun, Y.-X., Okamoto, Y., Araki, N., Tonai, T., & Ueda, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413473200 · Cited by 332
Petrosino, S., & Di Marzo, V. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 328
Self-citationChemical Basis of Hashish Activity
Mechoulam, R., Shani, A., Edery, H., & Grunfeld, Y. (1970) · Science · doi:10.1126/science.169.3945.611 · Cited by 326
De Petrocellis, L., Orlando, P., Moriello, A. S., Aviello, G., Stott, C., Izzo, A. A., & Di Marzo, V. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02338.x · Cited by 323
Self-citationPregnenolone Can Protect the Brain from Cannabis Intoxication
Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E., Kasanetz, F., Baillie, G. L., Panin, F., Cathala, A., et al. (2014) · Science · doi:10.1126/science.1243985 · Cited by 319
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
Chemin, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Maione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., & Marzo, V. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093286 · Cited by 294
Moreira, F. A., Kaiser, N., Monory, K., & Lutz, B. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.005 · Cited by 281
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279
Kang, C., Wang, B., Kaliannan, K., Wang, X., Lang, H., Hui, S., Huang, L., Zhang, Y., Zhou, M., Chen, M., et al. (2017) · mBio · doi:10.1128/mbio.00470-17 · Cited by 272
The anandamide transport inhibitor AM404 activates vanilloid receptors
Zygmunt, P. M., Chuang, H.-H., Movahed, P., Julius, D., & Högestätt, E. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00207-7 · Cited by 270
Nomura, D. K., Lombardi, D. P., Chang, J. W., Niessen, S., Ward, A. M., Long, J. Z., Hoover, H. H., & Cravatt, B. F. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.05.009 · Cited by 270
Topol, E. J., Bousser, M.-G., Fox, K. A., Creager, M. A., Despres, J.-P., Easton, J. D., Hamm, C. W., Montalescot, G., Steg, P. G., Pearson, T. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60935-x · Cited by 266
Kohno, M., Hasegawa, H., Inoue, A., Muraoka, M., Miyazaki, T., Oka, K., & Yasukawa, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.175 · Cited by 263
Atwood, B. K., Huffman, J., Straiker, A., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00582.x · Cited by 262
Jadoon, K. A., Ratcliffe, S. H., Barrett, D. A., Thomas, E. L., Stott, C., Bell, J. D., O’Sullivan, S. E., & Tan, G. D. (2016) · Diabetes Care · doi:10.2337/dc16-0650 · Cited by 262
Bandoh, K., Aoki, J., Taira, A., Tsujimoto, M., Arai, H., & Inoue, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01827-5 · Cited by 261
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 252
McHugh, D., Page, J., Dunn, E., & Bradshaw, H. B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01497.x · Cited by 250
Molecular Pharmacology of Phytocannabinoids
Turner, S. E., Williams, C. M., Iversen, L., & Whalley, B. J. (2017) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-319-45541-9_3 · Cited by 238
Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R. G. P., Cochez, P., Pierard, F., Castel, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6648 · Cited by 237
Lichtman, A. H., Lux, E. A., McQuade, R., Rossetti, S., Sanchez, R., Sun, W., Wright, S., Kornyeyeva, E., & Fallon, M. T. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.09.001 · Cited by 234
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 228
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Schubart, C. D., Sommer, I. E. C., van Gastel, W. A., Goetgebuer, R. L., Kahn, R. S., & Boks, M. P. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.017 · Cited by 226
Herman, T. S., Einhorn, L. H., Jones, S. E., Nagy, C., Chester, A. B., Dean, J. C., Furnas, B., Williams, S. D., Leigh, S. A., Dorr, R. T., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197906073002302 · Cited by 216
Meiri, E., Jhangiani, H., Vredenburgh, J. J., Barbato, L. M., Carter, F. J., Yang, H.-M., & Baranowski, V. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x167525 · Cited by 214
A FAAH-Regulated Class of N-Acyl Taurines That Activates TRP Ion Channels
Saghatelian, A., McKinney, M. K., Bandell, M., Patapoutian, A., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi0608008 · Cited by 212
Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G. M., Drago, F., & Di Marzo, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.98 · Cited by 207
Maione, S., De Petrocellis, L., de Novellis, V, Moriello, A. S., Petrosino, S., Palazzo, E., Rossi, F. S., Woodward, D. F., & Di Marzo, V (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707145 · Cited by 196
Self-citationMorgese, M. G., Cassano, T., Cuomo, V., & Giuffrida, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.021 · Cited by 196
Wiley, J. L., Marusich, J. A., & Huffman, J. W. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.09.011 · Cited by 194
Harnessing Gut Microbes for Mental Health: Getting From Here to There
Bruce-Keller, A. J., Salbaum, J. M., & Berthoud, H.-R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.014 · Cited by 189
Hansen, H. S., Rosenkilde, M. M., Holst, J. J., & Schwartz, T. W. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.014 · Cited by 186
Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
Labar, G., Bauvois, C., Borel, F., Ferrer, J., Wouters, J., & Lambert, D. M. (2010) · ChemBioChem · doi:10.1002/cbic.200900621 · Cited by 185
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Duggan, K. C., Hermanson, D. J., Musee, J., Prusakiewicz, J. J., Scheib, J. L., Carter, B. D., Banerjee, S., Oates, J. A., & Marnett, L. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.663 · Cited by 184
Ignatowska-Jankowska, B. M., Baillie, G. L., Kinsey, S., Crowe, M., Ghosh, S., Owens, R. A., Damaj, I. M., Poklis, J., Wiley, J. L., Zanda, M., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.148 · Cited by 177
Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 175
Self-citationNavia-Paldanius, D., Savinainen, J. R., & Laitinen, J. T. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m030411 · Cited by 175
Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
Bisogno, T., Melck, D., De Petrocellis, L., Bobrov, M. Y., Gretskaya, N. M., Bezuglov, V. V., Sitachitta, N., Gerwick, W. H., & Marzo, V. D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8874 · Cited by 173
Marcu, J. P., Christian, R. T., Lau, D., Zielinski, A. J., Horowitz, M. P., Lee, J., Pakdel, A., Allison, J., Limbad, C., Moore, D. H., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0407 · Cited by 173
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
Kerbrat, A., Ferré, J.-C., Fillatre, P., Ronzière, T., Vannier, S., Carsin-Nicol, B., Lavoué, S., Vérin, M., Gauvrit, J.-Y., Le Tulzo, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604221 · Cited by 171
Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’
Di Marzo, V., & Fontana, A. (1995) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90077-2 · Cited by 170
Self-citationGeurts, L., Everard, A., Van Hul, M., Essaghir, A., Duparc, T., Matamoros, S., Plovier, H., Castel, J., Denis, R. G. P., Bergiers, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7495 · Cited by 169
Bauer, M., Chicca, A., Tamborrini, M., Eisen, D., Lerner, R., Lutz, B., Poetz, O., Pluschke, G., & Gertsch, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382481 · Cited by 168
Navarro, G., Morales, P., Rodríguez‐Cueto, C., Fernández‐Ruíz, J., Jagerovic, N., & Franco, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00406 · Cited by 168
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00170-4 · Cited by 167
Fernández‐Ruíz, J., Romero, J., & Ramos, J. A. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_8 · Cited by 162
Role of the endocannabinoid system in diabetes and diabetic complications
Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13226 · Cited by 161
PETROCELLIS, L. D., Starowicz, K., Moriello, A. S., Vivese, M., Orlando, P., & Marzo, V. D. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.008 · Cited by 161
McPartland, J. M., Guy, G. W., & Di Marzo, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089566 · Cited by 161
Self-citationLee, J.-W., Huang, B. X., Kwon, H., Rashid, M. A., Kharebava, G., Desai, A., Patnaik, S., Marugan, J., & Kim, H.-Y. (2016) · Nature Communications · doi:10.1038/ncomms13123 · Cited by 161
Mehrpouya-Bahrami, P., Chitrala, K. N., Ganewatta, M. S., Tang, C., Murphy, E. A., Enos, R. T., Velazquez, K. T., McCellan, J., Nagarkatti, M., & Nagarkatti, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-15154-6 · Cited by 161
López-Sendón Moreno, J. L., García Caldentey, J., Trigo Cubillo, P., Ruiz Romero, C., García Ribas, G., Alonso Arias, M. A. A., García de Yébenes, M. J., Tolón, R. M., Galve-Roperh, I., Sagredo, O., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8145-9 · Cited by 160
Interactions between synthetic vanilloids and the endogenous cannabinoid system
Di Marzo, V., Bisogno, T., Melck, D., Ross, R., Brockie, H., Stevenson, L., Pertwee, R., & De Petrocellis, L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01175-2 · Cited by 158
Self-citationPathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?
Schmid, H. H. O. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00188-2 · Cited by 157
Jin, X.-H., Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606369200 · Cited by 155
Snider, N. T., Walker, V. J., & Hollenberg, P. F. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.001081 · Cited by 152
Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., Stott, C., Javid, F., Parker, L., & Pertwee, R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12043 · Cited by 151
Hu, S. S., Bradshaw, H. B., Chen, J. S., Tan, B., & Walker, J. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.33 · Cited by 151
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149
Piscitelli, F., Carta, G., Bisogno, T., Murru, E., Cordeddu, L., Berge, K., Tandy, S., Cohn, J. S., Griinari, M., Banni, S., et al. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-51 · Cited by 148
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Nadal, X., del Río, C., Casano, S., Palomares, B., Ferreiro‐Vera, C., Navarrete, C. M., Callado, C. S.-C., Cantarero, I., Bellido, M. L., Meyer, S., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14019 · Cited by 148
Gillum, M. P., Zhang, D., Zhang, X., Erion, D. M., Jamison, R. A., Choi, C., Dong, J., Shanabrough, M., Duenas, H. R., Frederick, D. W., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.043 · Cited by 147
Cluny, N. L., Keenan, C. M., Reimer, R. A., Foll, B. L., & Sharkey, K. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144270 · Cited by 142
Microbial metabolites in health and disease: Navigating the unknown in search of function
Martinez, K., Leone, V., & Chang, E. B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.752899 · Cited by 142
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins
Oddi, S., Fezza, F., Pasquariello, N., D'Agostino, A., Catanzaro, G., Simone, C. D., Rapino, C., Finazzi‐Agrò, A., & Maccarrone, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.004 · Cited by 140
Badowski, M. E. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3387-5 · Cited by 140
Slivicki, R. A., Xu, Z., Kulkarni, P. M., Pertwee, R. G., Mackie, K., Thakur, G. A., & Hohmann, A. G. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.032 · Cited by 139
Oxidative Metabolism of Endocannabinoids by COX-2
Kozak, K. R., Prusakiewicz, J. J., & Marnett, L. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453081 · Cited by 137
Varvel, S., Bridgen, D., Tao, Q., Thomas, B., Martin, B., & Lichtman, A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080739 · Cited by 135
Bedse, G., Bluett, R. J., Patrick, T. A., Romness, N. K., Gaulden, A. D., Kingsley, P. J., Plath, N., Marnett, L. J., & Patel, S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0141-7 · Cited by 135
Weber, A., Ni, J., Ling, K.-H. J., Acheampong, A., Tang‐Liu, D. D., Burk, R. M., Cravatt, B. F., & Woodward, D. F. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300475-jlr200 · Cited by 130
Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
Marzo, V. D., Lastres‐Becker, I., Bisogno, T., PETROCELLIS, L. D., Milone, A., Davis, J. B., & Fernández‐Ruíz, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01012-3 · Cited by 127
Ostenfeld, T., Price, J. A., Albanese, M., Bullman, J., Guillard, F., Meyer, I., Leeson, R., Costantin, C., Ziviani, L., Nocini, P. F., et al. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318219799a · Cited by 126
Lötsch, J., Weyer-Menkhoff, I., & Tegeder, I. (2017) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 126
T-Type Calcium Channel Inhibition Underlies the Analgesic Effects of the Endogenous Lipoamino Acids
Barbara, G., Alloui, A., Nargeot, J., Lory, P., Eschalier, A., Bourinet, E., & Chemin, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2919-09.2009 · Cited by 125
Emerging drugs of abuse: current perspectives on synthetic cannabinoids
Debruyne, D., & Boisselier, R. L. (2015) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s73586 · Cited by 125
A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines
Ogura, Y., Parsons, W. H., Kamat, S. S., & Cravatt, B. F. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2127 · Cited by 125
Raboune, S., Stuart, J. M., Leishman, E., Takacs, S. M., Rhodes, B. P., Basnet, A., Jameyfield, E., McHugh, D., Widlanski, T. S., & Bradshaw, H. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00195 · Cited by 123
Nakane, S., Oka, S., Arai, S., Waku, K., Ishima, Y., Tokumura, A., & Sugiura, T. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00038-3 · Cited by 116
Wargent, E. T., Zaibi, M. S., Silvestri, C., Hislop, D. C., Stocker, C. J., Stott, C. G., Guy, G. W., Duncan, M., Marzo, V. D., & Cawthorne, M. A. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.9 · Cited by 115
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
Puighermanal, E., Busquets-García, A., Maldonado, R. J., & Ozaita, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0384 · Cited by 114
Rock, E. M., Goodwin, J. M., Limebeer, C. L., Breuer, A., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2157-4 · Cited by 111
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
Silvestri, C., Paris, D., Martella, A., Melck, D. J., Guadagnino, I., Cawthorne, M., Motta, A., & Marzo, V. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.001 · Cited by 108
Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A. H., Maione, S., & Marzo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031111 · Cited by 108
Wu, D., Yang, L., Goschke, A., Stumm, R. K., Brandenburg, L., Liang, Y.-J., Höllt, V., & Koch, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05063.x · Cited by 107
Tambaro, S., & Bortolato, M. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912798842269 · Cited by 107
Valdeolivas, S., Satta, V., Pertwee, R. G., Fernández‐Ruíz, J., & Sagredo, O. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200114w · Cited by 107
The CB1 Receptor as the Cornerstone of Exostasis
Piazza, P. V., Cota, D., & Marsicano, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.002 · Cited by 107
Comelli, F., Giagnoni, G., Bettoni, I., Colleoni, M., & Costa, B. (2008) · Phytotherapy Research · doi:10.1002/ptr.2401 · Cited by 103
Imperatore, R., Morello, G., Luongo, L., Taschler, U., Romano, R., Gregorio, D. D., Belardo, C., Maione, S., Marzo, V. D., & Cristino, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13267 · Cited by 100
GPR3 and GPR6, novel molecular targets for cannabidiol
Laun, A. S., & Song, Z.-H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.165 · Cited by 100
Starowicz, K., Makuch, W., Korostyński, M., Małek, N., Ślęzak, M., Żychowska, M., Petrosino, S., PETROCELLIS, L. D., Cristino, L., Przewłocka, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060040 · Cited by 99
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Nguyen, T., Li, J., Thomas, B. F., Wiley, J. L., Kenakin, T., & Zhang, Y. (2016) · Medicinal Research Reviews · doi:10.1002/med.21418 · Cited by 99
Valdeolivas, S., Pazos, M. R., Bisogno, T., Piscitelli, F., Iannotti, F. A., Allarà, M., Sagredo, O., Marzo, V. D., & Fernández‐Ruíz, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.387 · Cited by 97
Karwad, M. A., Macpherson, T., Wang, B., Theophilidou, E., Sarmad, S., Barrett, D. A., Larvin, M., Wright, K. L., Lund, J. N., & O’Sullivan, S. E. (2016) · The FASEB Journal · doi:10.1096/fj.201500132 · Cited by 97
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Chicca, A., Nicolussi, S., Bartholomäus, R., Blunder, M., Rey, A. A., Petrucci, V., Reynoso-Moreno, I., Paredes, J. M. V., Gens, M. D., Lutz, B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704065114 · Cited by 97
Connor, M. A., Vaughan, C. W., & Vandenberg, R. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00862.x · Cited by 96
Cannabis and Endocannabinoid Signaling in Epilepsy
Katona, I. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_10 · Cited by 96
Iannotti, F. A., Silvestri, C., Mazzarella, E., Martella, A., Calvigioni, D., Piscitelli, F., Ambrosino, P., Petrosino, S., Czifra, G., Bı́ró, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406728111 · Cited by 96
Dziadulewicz, E. K., Bevan, S., Brain, C. T., Coote, P. R., Culshaw, A. J., Aj, D., Edwards, L. J., Fisher, A. J., Fox, A. J., Gentry, C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070317a · Cited by 96
Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice
Paronis, C. A., Nikas, S. P., Shukla, V. G., & Makriyannis, A. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835a7c4d · Cited by 94
Liang, Y., Woodward, D. F., Guzman, V. M., Li, C., Scott, D. F., Wang, J. W., Wheeler, L. A., Garst, M. E., Landsverk, K., Sachs, G. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.142 · Cited by 93
Keating, G. M. (2017) · Drugs · doi:10.1007/s40265-017-0720-6 · Cited by 92
Oleoyl serine, an endogenous N -acyl amide, modulates bone remodeling and mass
Smoum, R., Bar, A., Tan, B., Milman, G., Attar-Namdar, M., Ofek, O., Stuart, J. M., Bajayo, A., Tam, J., Kram, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912479107 · Cited by 91
Sagar, D. R., Kendall, D. A., & Chapman, V. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.335 · Cited by 90
Luchicchi, A., Lecca, S., Carta, S., Pillolla, G., Muntoni, A. L., Yaşar, S., Goldberg, S. R., & Pistis, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00222.x · Cited by 89
de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega‐Gutiérrez, S., Fernández‐Ruíz, J., & Marzo, V. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.011 · Cited by 89
Cannabinoids as Anticancer Drugs
Ramer, R., & Hinz, B. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.002 · Cited by 89
McKillop, A. M., Moran, B. M., Abdel‐Wahab, Y. H. A., & Flatt, P. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12356 · Cited by 86
Haj‐Dahmane, S., Shen, R., Elmes, M. W., Studholme, K. M., Kanjiya, M. P., Bogdan, D., Thanos, P. K., Miyauchi, J. T., Tsirka, S. E., Deutsch, D. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721339115 · Cited by 86
Gomes, F. V., Bel, E. A. D., & Guimarães, F. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.005 · Cited by 85
Navarria, A., Tamburella, A., Iannotti, F. A., Micale, V., Camillieri, G., Gozzo, L., Verde, R., Imperatore, R., Leggio, G. M., Drago, F., et al. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.014 · Cited by 85
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
Bishay, P., Schmidt, H., Marian, C., Häußler, A., Wijnvoord, N., Ziebell, S., Metzner, J., Koch, M., Myrczek, T., Bechmann, I., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010628 · Cited by 85
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice
Busquets-García, A., Gómez, E. S., Redon, B., Mackenbach, Y., Vallée, M., Chaouloff, F., Varilh, M., Ferreira, G., Piazza, P.-V., & Marsicano, G. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.4 · Cited by 84
Actions and Regulation of Ionotropic Cannabinoid Receptors
PETROCELLIS, L. D., Nabissi, M., Santoni, G., & Ligresti, A. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.001 · Cited by 83
Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 81
Hu, S. S., Bradshaw, H. B., Benton, V. M., Chen, J. S.-C., Huang, S. M., Minassi, A., Bisogno, T., Masuda, K. R., Tan, B., Roskoski, R. J., et al. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.026 · Cited by 80
Petrucci, V., Chicca, A., Glasmacher, S., Pálóczi, J., Cao, Z., Pacher, P., & Gertsch, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09808-8 · Cited by 80
Verhoeckx, K. C. M., Voortman, T., Balvers, M. G. J., Hendriks, H., Wortelboer, H. M., & Witkamp, R. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.008 · Cited by 79
Fatty acids, endocannabinoids and inflammation
Witkamp, R. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.051 · Cited by 78
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
Roser, P., Vollenweider, F. X., & Kawohl, W. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970801908047 · Cited by 78
Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain
Velasco‐Estevez, M., O'Sullivan, C., & Sheridan, G. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.002 · Cited by 78
Wilkerson, J. L., Ghosh, S., Mustafa, M., Abdullah, R. A., Niphakis, M. J., Cabrera, R., Maldonado, R. L., Cravatt, B. F., & Lichtman, A. H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.015 · Cited by 78
Bisogno, T., Mahadevan, A., Coccurello, R., Chang, J. W., Allarà, M., Chen, Y., Giacovazzo, G., Lichtman, A. H., Cravatt, B. F., Moles, A., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12013 · Cited by 77
Ramesh, D., Gamage, T. F., Vanuytsel, T., Owens, R. A., Abdullah, R. A., Niphakis, M. J., Shea‐Donohue, T., Cravatt, B. F., & Lichtman, A. H. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.269 · Cited by 76
Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice
Monory, K., Tzavara, E. T., Lexime, J., Ledent, C. A., Parmentier, M., Borsodi, A. D., & Hanoune, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6635 · Cited by 75
Johnson, D. E., Heald, S. L., Dally, R. D., et al. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90048-2 · Cited by 74
Finlay, D. B., Joseph, W. R., Grimsey, N. L., & Glass, M. (2016) · PeerJ · doi:10.7717/peerj.1835 · Cited by 74
The role of CB 1 in intestinal permeability and inflammation
Karwad, M. A., Couch, D. G., Theophilidou, E., Sarmad, S., Barrett, D. A., Larvin, M., Wright, K. L., Lund, J. N., & O’Sullivan, S. E. (2017) · The FASEB Journal · doi:10.1096/fj.201601346r · Cited by 73
Sharma, M. K., Murumkar, P. R., Kanhed, A. M., Giridhar, R., & Yadav, M. R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.011 · Cited by 72
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
Alhouayek, M., Masquelier, J., & Muccioli, G. G. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.009 · Cited by 71
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Morales, P., Hernández‐Folgado, L., Goya, P., & Jagerovic, N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1193157 · Cited by 71
金, 星. (2007) · Medical Entomology and Zoology · Cited by 71
Lysophosphatidic acid receptors in cancer pathobiology.
Tsujiuchi, T., Araki, M., Hirane, M., Dong, Y., & Fukushima, N. (2014) · PubMed · doi:10.14670/hh-29.313 · Cited by 70
The therapeutic potential of targeting the peripheral endocannabinoid/CB 1 receptor system
Tam, J., Hinden, L., Drori, A., Udi, S., Azar, S., & Baraghithy, S. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.01.009 · Cited by 70
Ross, H., Gilmore, A. J., & Connor, M. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00072.x · Cited by 69
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Hasenoehrl, C., Storr, M., & Schicho, R. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1292851 · Cited by 69
Abdelhamid, R. E., Kovács, K. J., Nunez, M. G., & Larson, A. A. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.10.006 · Cited by 68
Baggelaar, M. P., Chameau, P. J. P., Kantae, V., Hummel, J. J. A., Hsu, K., Janssen, F. J., van der Wel, T., Soethoudt, M., Deng, H., den Dulk, H., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b04883 · Cited by 68
Kawahara, H., Drew, G., Christie, M., & Vaughan, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01157.x · Cited by 67
Cascio, M. G., Zamberletti, E., Marini, P., Parolaro, D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13000 · Cited by 67
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System
Chicca, A., Caprioglio, D., Minassi, A., Petrucci, V., Appendino, G., Taglialatela‐Scafati, O., & Gertsch, J. (2014) · ACS Chemical Biology · doi:10.1021/cb500177c · Cited by 67
Cited by
Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Review of the Endocannabinoid System
Lu, H.-C., & Mackie, K. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.07.016 · Cited by 491
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Metadata
- Authors
- Di Marzo, V.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-08-17
- Volume
- 17
- Issue
- 9
- Pages
- 623-639
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2886046928
- Cited by
- 480
- References
- 256
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.